Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BreatheND is a medical technology company focused on developing non-invasive diagnostic tools for monitoring respiratory health. Spun out of research from the University of Notre Dame, the company utilizes advanced sensor technology to analyze biomarkers in exhaled breath. Their primary goal is to provide real-time, point-of-care monitoring for patients with chronic respiratory conditions such as asthma and COPD. By enabling early detection of respiratory distress, BreatheND aims to reduce hospitalizations and improve the quality of life for patients managing chronic lung diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BreatheND.